Search results
Showing 91 to 105 of 734 results for diabet*
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (TA151)
Evidence-based recommendations on continuous subcutaneous insulin infusion (insulin pump therapy) for treating type 1 diabetes in adults and children.
Evidence-based recommendations on tirzepatide (Mounjaro) for type 2 diabetes in adults.
Evidence-based recommendations on ertugliflozin (Steglatro) with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes in adults.
Awaiting development Reference number: GID-TA10439 Expected publication date: TBC
Awaiting development Reference number: GID-TA10665 Expected publication date: TBC
Awaiting development Reference number: GID-TA10438 Expected publication date: TBC
In development Reference number: GID-NG10450 Expected publication date: TBC
In development Reference number: GID-NG10336 Expected publication date: 18 February 2026
Semaglutide for treating type 2 diabetes in people 10 to 17 years [TSID12249]
Topic prioritisation
Topic prioritisation
In development Reference number: GID-TA10981 Expected publication date: 08 April 2026
In development Reference number: GID-TA11644 Expected publication date: 22 October 2026